Literature DB >> 1083251

Inhibition of urokinase by complex formation with human alpha1-antitrypsin.

I Clemmensen, F Christensen.   

Abstract

Human alpha1-antitrypsin was prepared from fresh human plasma by (NH4)-SO4-precipitation, gel filtration, affinity chromatography on concanavalin A, ion exchange chromatography and isotachophoresis. Human urokinase (EC 3.4.99.26) (plasminogen activator from urine) with M, 46 000 and 36 000 was further purified from Urokinase Leo reagent preparation by gel filtration on Sephadex G-100 Superfine. The hydrolytic activity of urokinase on acetyl-glycyl-L-lysine methyl ester acetate (Ac-Gly-Lys-OMeAc) was inhibited in a strong time-dependent manner by alpha1-antitrypsin. Complex formation between enzyme and inhibitor could be demonstrated in crossed immunoelectrophoresis against anti-alpha1-antitrypsin and anti-urokinase serum as well as by sodium dodecyl sulphate polyacrylamide gel electrophoresis. The latter method revealed the formation of 1:1 and 2:1 molar enzyme-inhibitor complexes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083251     DOI: 10.1016/0005-2744(76)90307-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.

Authors:  S Thorsen; S Müllertz; E Suenson; P Kok
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

2.  Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.

Authors:  S Müllertz; S Thorsen; L Sottrup-Jensen
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

Review 3.  Natural inhibitors of fibrinolysis.

Authors:  D Collen
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

Review 4.  Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.

Authors:  Ignacio Blanco; Beatriz Lara; Frederick de Serres
Journal:  Orphanet J Rare Dis       Date:  2011-04-12       Impact factor: 4.123

5.  Complex-formation and inhibition of urokinase by blood plasma proteins.

Authors:  E K Waller; W D Schleuning; E Reich
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

6.  Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.

Authors:  E Suenson; S Thorsen
Journal:  Biochem J       Date:  1981-09-01       Impact factor: 3.857

Review 7.  Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms.

Authors:  Jordan R Yaron; Liqiang Zhang; Qiuyun Guo; Shelley E Haydel; Alexandra R Lucas
Journal:  Front Cardiovasc Med       Date:  2021-03-25

8.  Characterization of a 54 kDa, alpha 1-antitrypsin-like protein isolated from ascitic fluid of an endometrial cancer patient.

Authors:  N Tanaka; S Sekiya; H Takamizawa; N Kato; Y Moriyama; S Fujimura
Journal:  Jpn J Cancer Res       Date:  1991-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.